Filgrastim

Photos »

  /  
Related News »
The company discovers, develops, manufactures and markets medicines for illnesses. Its products are Neulasta (pegfilgrastim), a pegylated protein, based on the Filgrastim molecule, and NEUPOGEN (Filgrastim), a recombinant-methionyl human granulocyte colony ...
May 28, 2012 at 06:49 | Source: Seekingalpha.com
It's important to note that while O'Connor was asked to donate bone marrow, the majority of donors are asked for stem cells, which are extracted via a non-surgical procedure after the patient takes a drug called filgrastim for several days to increase the ...
May 23, 2012 at 20:45 | Source: NorthJersey.com
Its products include anemia treatment Retacrit in the EU and biosimilar filgrastim product Nivestim, sold in the EU and Australia for stimulating production of white blood cells in patients receiving cytotoxic chemotherapy. Samant Ramachandra ...
May 15, 2012 at 20:26 | Source: Genetic Engineering News
In 2010, the G-CSF biosimilars had a 33% share in the global biosimilars market. It is expected that the patent expiries of Neupogen (filgrastim) in 2013 and Neulasta (pegfilgrastim) in 2015 will make the way for the entry of G-CSF biosimilars ...
May 18, 2012 at 03:26 | Source: SBWire